newest glp-1 New Guidelines for Type 2 Diabetes in 2025 or yogurt—without meaningfully affecting its taste or texture Retatrutide for weight loss: Study

Tirzepatide has a slightly higher molecular weight, which theoretically makes it even less likely to transfer into milk, but both appear similarly safe based on available studies

A qualified healthcare team can interpret these insights alongside your disease activity markers and current DMARD therapy

GLP-1 medications are typically considered for adults who: Have a Body Mass Index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as diabetes or hypertension Have not achieved sustained weight loss through lifestyle modification alone These medications are intended for long-term weight management, not short-term or cosmetic weight loss

Lifestyle modifications, while not curative for lipedema tissue itself, support overall health and may help manage concurrent obesity

Over six years, they identified approximately 100 cases annually, noting the highest risk within the first year of medication use

Clinically, long acting GLP-1 mimetics are now used to treat Type 2 diabetes